Navigation Links
Shire Continues to Deliver Excellent Growth From Core Products
Date:10/30/2009

$48.3 million, an increase of 8% (2008: $44.6 million). Expressed on a CER basis product sales increased by 15% (REPLAGAL is primarily sold in Euros and Pounds Sterling). The product sales growth was driven by increased volumes in Europe and Asia Pacific.

FIRAZYR - HAE

Product sales for the three months to September 30, 2009 were $1.8 million (2008: $0.2 million). With a Q3 launch in Italy, FIRAZYR is now marketed in the five largest European countries. FIRAZYR is the first new product for HAE in Europe in 30 years and has orphan exclusivity in the EU until 2018.

3. Royalties

Royalty revenue decreased by 1% to $60.3 million for the three months to September 30, 2009 (2008: $60.8 million). The following table provides an analysis of Shire's royalty revenue:

                             Royalties to Shire      Year on year
    Product                          $M               change(1)       CER(2)
    3TC(R) and ZEFFIX(R)            42.0                 -6%            0%
    ADDERALL XR                     2.2                  n/a           n/a
    Other                           16.1                 -1%           n/a
    Total                           60.3                 -1%            0%

    (1) Compared with Q3 2008

    (2) CER growth, which is a Non GAAP measure, is calculated after
        restating Q3 2009 results using Q3 2008 average foreign exchange
        rates.

Royalties from Teva's sales of authorized generic ADDERALL XR for the three months to September 30, 2009 were $2.2 million (2008: $nil). Receipt of this royalty began with Teva's sales of an authorized generic version of ADDERALL XR in April 2009 and ceased in September 2009. From Q4 2009, Shire will receive royalties on Impax's sales of its authorized generic version of ADDERALL XR.

    4. Financial details

    Cost of product sales
                                                      % 
'/>"/>
SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
8. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
9. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)...  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today announced the ... common stock and warrants at a price of $10,000 ... to deducting underwriting discounts and commissions and offering expenses ... immediately separable and will be issued separately.  The shares ... The NASDAQ Stock Market under the ticker symbol "WGBS" ...
(Date:8/21/2014)... 2014   Memorial Hermann Health System and ... announced a new partnership to provide a new level of ... centers in the greater Houston area. ... the exclusive provider of professional breast radiology services for five ... City, The Woodlands , Northeast, Southwest and ...
(Date:8/21/2014)... Nektar Therapeutics (NASDAQ: NKTR ... results from its Phase 3 pivotal clinical trial ... factor VIII (rFVIII) treatment for hemophilia A based ... primary endpoint in reducing annualized bleed rates (ABR) ... arm. Top-line results from the prospective, ...
Breaking Medicine Technology:WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5
(Date:8/22/2014)... 22, 2014 For patients who need surgery for ... procedure is the least often used, reports a study ... , official journal of the Congress of Neurological ... Williams & Wilkins , a part of Wolters ... good pain relief at much lower cost than other ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Pirate ... expansion of products in providing new recipe cards, fun ... wear. , Hailing from Clearwater, Florida, Pirate Jonny, ... having 1 card with two to three recipes featuring ... recipes on the website. The recipe ...
(Date:8/22/2014)... Society for Medical Oncology (ESMO), the leading pan-European ... names of three outstanding individuals receiving the Society,s ... to Carsten Bokemeyer, Heikki Joensuu and Peter Boyle ... 26-30 September, Madrid, Spain. , Carsten Bokemeyer will ... accelerate the transition of cancer discovery into real ...
(Date:8/22/2014)... 22, 2014 A new study finds a wide ... may be related to key environmental exposuresin children with Crohn,s ... official journal of the Crohn,s & Colitis Foundation of ... Lippincott Williams & Wilkins , a part of Wolters ... evidence" of alterations of DNA in several regions of the ...
(Date:8/22/2014)... recall the dramatic images of nurses at New York ... hundred patients, carrying many including the youngest and most ... resulting from the storm surge generated by Hurricane Sandy. ... the New York University Colleges of Nursing (NYUCN) and ... Urban Health examines the impact on NYULMC nurses, ...
Breaking Medicine News(10 mins):Health News:More common procedures for painful facial tics carry high costs, reports study in Neurosurgery 2Health News:Pirate Jonny's Caribbean BBQ Rubs, Seasonings & Sauces Get New Look by Hoisting New Recipe Card Creations and New Clothing Apparel for its Logos 2Health News:ESMO honors outstanding oncology professionals 2Health News:ESMO honors outstanding oncology professionals 3Health News:Study shows epigenetic changes in children with Crohn's disease 2Health News:Study identifies challenges faced by NYU nurses after Hurricane Sandy 2Health News:Study identifies challenges faced by NYU nurses after Hurricane Sandy 3
... Amanda Gardner HealthDay Reporter , MONDAY, Oct. 11 ... higher risk for stroke even if they don,t have full-blown ... people who show signs of insulin resistance -- a reduction ... from the bloodstream -- may be helpful in preventing stroke, ...
... Health care in the last six months of life has ... among Medicare beneficiaries in the United States and older adults ... final six months of life in both countries, according to ... the February 14 print issue of Archives of Internal ...
... retinal conditions nearly doubled between 1997 and 2007, with ... performed, according to a report in the October issue ... JAMA/Archives journals. "Retinal disease is highly prevalent among ... diabetic retinopathy account for more than half the irreversible ...
... , MONDAY, Oct. 11 (HealthDay News) -- Pre-teens who spent ... TV or computer were at greater risk of having psychological ... kids also tended to be physically active, new research finds. ... November print issue of Pediatrics , found that the ...
... By Jenifer Goodwin HealthDay Reporter , ... have jaundice may be at higher risk of developing ... said far more research needs to be done before ... analyzed information from national registries that included all Danish ...
... disparities in the receipt of breast cancer care persist ... status. That is the conclusion of a study published ... of the American Cancer Society. The findings suggest that ... breast cancer care and to ensure that all affected ...
Cached Medicine News:Health News:Insulin Resistance Might Raise Risk of Stroke 2Health News:Insulin Resistance Might Raise Risk of Stroke 3Health News:End-of-life care patterns shift for patients with heart failure in both US and Canada 2Health News:End-of-life care patterns shift for patients with heart failure in both US and Canada 3Health News:End-of-life care patterns shift for patients with heart failure in both US and Canada 4Health News:End-of-life care patterns shift for patients with heart failure in both US and Canada 5Health News:Treatment of retinal conditions appears to have changed significantly in previous decade 2Health News:Could Excess Computer, TV Time Harm Kids Psychologically? 2Health News:Could Excess Computer, TV Time Harm Kids Psychologically? 3Health News:Danish Study Suggests Jaundice-Autism Link 2Health News:Danish Study Suggests Jaundice-Autism Link 3Health News:Insurance and socioeconomic status do not explain racial disparities in breast cancer care 2
... and fourth year medical students on ... easy access in a rapid-fire Q&A ... lab coat pocket, this reference is ... prior to surgical rounds as well ...
With its extensive content and custom-designed user interface, Schwartz Principles of Surgery, PDA Edition enables you quick access to the answers you need to make the right diagnosis or initiate a t...
This handy reference contains all of the essential information that surgical residents and medical students need to have at their fingertips for day-to-day patient care....
This book includes orthopedic, reproductive, renal, cardiovascular, GI, and respiratory problems; and other common conditions....
Medicine Products: